A study evaluating effect of sodium stibogluconate on signature biomarkers for visceral leishmaniasis.
Latest Information Update: 23 Jan 2018
At a glance
- Drugs Sodium stibogluconate (Primary)
- Indications Leishmaniasis
- Focus Biomarker; Pharmacodynamics
- 23 Jan 2018 New trial record